What’s Driving the Higher Breast Cancer Death Rate in Black Women?April 18, 2024Breast CancerBusiness of MedicineDiversity in MedicineOncologyWomen's Health
Certain Women May Face Higher Risk for Second Breast CancerApril 17, 2024Breast CancerOncologyWomen's Health
Meat Linked to Higher Erectile Dysfunction RiskApril 16, 2024OncologyGenitourinary CancerProstate Cancer
Blood Test Shows Promise for Improving CRC ScreeningApril 16, 2024Colorectal CancerOncologyColon and Rectal
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024MelanomaLung CancerGenitourinary CancerBreast CancerOncologyAMLBusiness of Medicine
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024Breast CancerGenitourinary CancerMelanomaLung CancerMixed TopicsMultiple MyelomaMyelodysplastic Syndrome
Further Support for CRC Screening to Start at Age 45: Meta-AnalysisApril 12, 2024OncologyColon and Rectal
Repeat MCED Testing May ID Early-Stage and Unscreened CancersApril 10, 2024Breast CancerGenitourinary CancerLung CancerMelanomaOncologyProstate Cancer
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Breast CancerGenitourinary CancerMelanomaMixed TopicsAMLMultiple MyelomaOncology
New Quality Measure Improves Follow-Up for CRC ScreeningApril 9, 2024OncologyBusiness of MedicineColon and Rectal
EBER-Negative, Double-Hit High-Grade B-Cell Lymphoma Responding to Methotrexate DiscontinuationApril 8, 2024OncologyProstate Cancer
